Evidence map›Paper›PMID 31275691›Full record

ArticleCase reports in vascular medicine2019

Rare Clinical Course of Immunoglobulin G4-Related Inflammatory Abdominal Aortic Aneurysm with Multiple Rare Complications.

Yuji Naito, Tsukasa Miyatake, Manami Iwasaki, Atsushi Okuyama, Akio Takada, Koji Chiba, Masahiko Obata, Junichi Oba

Open access · goldAbstract readCase Reports
In one paragraph

Article in Case reports in vascular medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 91% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 1 country.

Yuji NaitoDepartment of Thoracic Surgery, Asahikawa City Hospital, Asahikawa, Japan.
Tsukasa MiyatakeDepartment of Cardiovascular Surgery, Hokko Memorial Hospital, Sapporo, Japan.ORCID 0000-0002-6848-3972
Manami IwasakiDepartment of Radiation Medicine, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
Atsushi OkuyamaDepartment of Internal Medicine, Fukagawa Municipal Hospital, Fukagawa, Japan.
Akio TakadaDepartment of Pathology, Asahikawa City Hospital, Asahikawa, Japan.
Koji ChibaDepartment of Hematology, Asahikawa City Hospital, Asahikawa, Japan.
Masahiko ObataDepartment of Pathology, Asahikawa Red Cross Hospital, Asahikawa, Japan.
Junichi ObaDepartment of Cardiovascular Surgery, Hokkaido Medical Center for Child Health and Rehabilitation, Sapporo, Japan.
Asahikawa City Hospital · JPFukuyama City Hospital · JPHokkaido University · JPHokko Memorial Hospital · JPJapanese Red Cross Asahikawa Hospital · JPNational Hospital Organization Hokkaido Medical Center · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Immunoglobulin G4- (IgG4-) related inflammatory abdominal aortic aneurysm (AAA) has been recognized as a manifestation of IgG4-related disease (IgG4-RD). We experienced one patient with multiple consecutive manifestations before and after endovascular stent grafting for IgG4-related inflammatory AAA (IAAA). A 71-year-old man was diagnosed with IgG4-RD due to increased IgG4 serum concentration, typical findings of parotid gland biopsy, and periaortitis in another hospital 2 years and 7 months before visiting our hospital. He came to our hospital because of abdominal pain and IAAA. He developed paraplegia after hospitalization and underwent endovascular stent grafting for the IAAA. About one month after stent grafting, he developed perforation of the sigmoid colon due to enteritis. He also had myocardial infarction. Finally, he died of intestinal bleeding. Here, we describe this case with rare, multiple, consecutive manifestations of IgG4-RD, some of which might be caused by IgG4-related IAAA or side effects of treatments rather than by IgG4-RD itself. We report this case because the clinical course seemed rare for IgG4-RD or IgG4-related IAAA. For treating IgG4-RD with IgG4-related IAAA, we should consider factors causing the symptoms and carefully select the proper treatment.

Identifiers

PMID31275691
PMCPMC6582838
OpenAlexW2948167279

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.